Dual Inhibition of Meningeal Mast Cells and Trigeminal Neurons via MRGPRX2 Antagonism in Migraine

Evommune Inc. published this content on June 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 29, 2026 at 13:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]